Search results
Results from the WOW.Com Content Network
There are three main treatment options available to treat soft tissue sarcoma in cats and dogs: surgery, radiation therapy, and chemotherapy. Surgery alone or in combination with radiation therapy are used to treat the tumor at its original location, and chemotherapy is usually used to prevent or at least slow down the process of metastasis in ...
Radiation therapy is mainly used as an adjuvant therapy for mastocytomas that cannot be completely removed and is considered the treatment of choice. Mast cells are very sensitive to ionizing radiation. For grade 2 mastocytomas, various studies show freedom from disease after one year in about 95% of patients, and between the second and fifth ...
According to Blue Cross, pet owners can expect for their pet to live about 12 months with current treatments. If the owner opts for palliative care instead of treatment, the dog will live about 3 months, although if the tumor is partially removed this can be extended. The survival time may be longer in large dogs, and the cure rate is 20%.
A review of radiation therapy randomised clinical trials from 2018 to 2021 found many practice-changing data and new concepts that emerge from RCTs, identifying techniques that improve the therapeutic ratio, techniques that lead to more tailored treatments, stressing the importance of patient satisfaction, and identifying areas that require ...
Fibrosarcoma occurs most frequently in the mouth in dogs. [7] The tumor is locally invasive, and often recurs following surgery. [8] Radiation therapy and chemotherapy are also used in treatment. Fibrosarcoma is also a rare bone tumor in dogs. [9]
FLASH radiotherapy is an emerging form of radiotherapy which delivers a high dose of radiation to the patient in an ultra-short time frame which produces a tumour killing effect comparable to conventional radiotherapy but with less damage to surrounding healthy tissue.
Targeted alpha-particle therapy (or TAT) is an in-development method of targeted radionuclide therapy of various cancers. It employs radioactive substances which undergo alpha decay to treat diseased tissue at close proximity. [1] It has the potential to provide highly targeted treatment, especially to microscopic tumour cells.
Radiation therapy is used to kill cancer cells; however, normal cells are also damaged in the process. Currently, therapeutic doses of radiation can be targeted to tumors with great accuracy using linear accelerators in radiation oncology; however, when irradiating using external beam radiotherapy, the beam will always need to travel through healthy tissue, and the normal liver tissue is very ...